My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1198

    1.

    Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.

    Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME, Forbes JM.

    Diabetes. 2008 Feb;57(2):460-9. Epub 2007 Oct 24.PMID: 17959934 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Comment on: Thallas-Bonke et al. (2008) Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway: Diabetes 57:460-469, 2008.

    Yamagishi S.

    Diabetes. 2008 Jun;57(6):e13; author reply e14. No abstract available. PMID: 18511442 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Attenuation of extracellular matrix accumulation in diabetic nephropathy by the advanced glycation end product cross-link breaker ALT-711 via a protein kinase C-alpha-dependent pathway.

    Thallas-Bonke V, Lindschau C, Rizkalla B, Bach LA, Boner G, Meier M, Haller H, Cooper ME, Forbes JM.

    Diabetes. 2004 Nov;53(11):2921-30.PMID: 15504973 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?

    Coughlan MT, Thallas-Bonke V, Pete J, Long DM, Gasser A, Tong DC, Arnstein M, Thorpe SR, Cooper ME, Forbes JM.

    Endocrinology. 2007 Feb;148(2):886-95. Epub 2006 Nov 16.PMID: 17110423 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of NADPH oxidase inhibitor in diabetic nephropathy.

    Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS.

    Kidney Int. 2005 May;67(5):1890-8.PMID: 15840036 [PubMed - indexed for MEDLINE]Related articles

    6.

    Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.

    Li L, Renier G.

    Metabolism. 2006 Nov;55(11):1516-23.PMID: 17046555 [PubMed - indexed for MEDLINE]Related articles

    7.

    Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the role of reducing oxidative stress in its protective property.

    Nam SM, Lee MY, Koh JH, Park JH, Shin JY, Shin YG, Koh SB, Lee EY, Chung CH.

    Diabetes Res Clin Pract. 2009 Feb;83(2):176-82. Epub 2008 Dec 25.PMID: 19111363 [PubMed - indexed for MEDLINE]Related articles

    8.

    RhoA/Rho-kinase contribute to the pathogenesis of diabetic renal disease.

    Peng F, Wu D, Gao B, Ingram AJ, Zhang B, Chorneyko K, McKenzie R, Krepinsky JC.

    Diabetes. 2008 Jun;57(6):1683-92. Epub 2008 Mar 20.PMID: 18356410 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Glycated albumin induces superoxide generation in mesangial cells.

    Yoo CW, Song CY, Kim BC, Hong HK, Lee HS.

    Cell Physiol Biochem. 2004;14(4-6):361-8.PMID: 15319540 [PubMed - indexed for MEDLINE]Related articles

    10.

    Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet.

    Tuttle KR, Anderberg RJ, Cooney SK, Meek RL.

    Am J Nephrol. 2009;29(3):171-80. Epub 2008 Sep 8.PMID: 18781061 [PubMed - indexed for MEDLINE]Related articles

    11.

    Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase.

    Wei XF, Zhou QG, Hou FF, Liu BY, Liang M.

    Am J Physiol Renal Physiol. 2009 Feb;296(2):F427-37. Epub 2008 Nov 19.PMID: 19019916 [PubMed - indexed for MEDLINE]Related articles

    12.

    Ras modulation of superoxide activates ERK-dependent fibronectin expression in diabetes-induced renal injuries.

    Lin CL, Wang FS, Kuo YR, Huang YT, Huang HC, Sun YC, Kuo YH.

    Kidney Int. 2006 May;69(9):1593-600.PMID: 16572112 [PubMed - indexed for MEDLINE]Related articles

    13.

    Inhibition of NAD(P)H oxidase alleviates impaired NOS-dependent responses of pial arterioles in type 1 diabetes mellitus.

    Mayhan WG, Arrick DM, Sharpe GM, Patel KP, Sun H.

    Microcirculation. 2006 Oct-Nov;13(7):567-75.PMID: 16990215 [PubMed - indexed for MEDLINE]Related articles

    14.

    Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes.

    Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R.

    FASEB J. 2000 Mar;14(3):439-47.PMID: 10698958 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Induction of reactive oxygen species from isolated rat glomeruli by protein kinase C activation and TNF-alpha stimulation, and effects of a phosphodiesterase inhibitor.

    Koike N, Takamura T, Kaneko S.

    Life Sci. 2007 Apr 10;80(18):1721-8. Epub 2007 Feb 9.PMID: 17346751 [PubMed - indexed for MEDLINE]Related articles

    16.

    Phosphatidylinositol 3'-kinase-dependent activation of renal mesangial cell Ki-Ras and ERK by advanced glycation end products.

    Xu D, Kyriakis JM.

    J Biol Chem. 2003 Oct 10;278(41):39349-55. Epub 2003 Jul 17.PMID: 12871951 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    N-phenacylthiazolium bromide decreases renal and increases urinary advanced glycation end products excretion without ameliorating diabetic nephropathy in C57BL/6 mice.

    Schwedler SB, Verbeke P, Bakala H, Weiss MF, Vilar J, Depreux P, Fourmaintraux E, Striker LJ, Striker GE.

    Diabetes Obes Metab. 2001 Aug;3(4):230-9.PMID: 11520302 [PubMed - indexed for MEDLINE]Related articles

    18.

    Advanced oxidation protein products promote inflammation in diabetic kidney through activation of renal nicotinamide adenine dinucleotide phosphate oxidase.

    Shi XY, Hou FF, Niu HX, Wang GB, Xie D, Guo ZJ, Zhou ZM, Yang F, Tian JW, Zhang X.

    Endocrinology. 2008 Apr;149(4):1829-39. Epub 2008 Jan 3.PMID: 18174276 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Novel inhibitors of glycation and AGE formation.

    Rahbar S.

    Cell Biochem Biophys. 2007;48(2-3):147-57.PMID: 17709884 [PubMed - indexed for MEDLINE]Related articles

    20.

    The diabetic milieu modulates the advanced glycation end product-receptor complex in the mesangium by inducing or upregulating galectin-3 expression.

    Pugliese G, Pricci F, Leto G, Amadio L, Iacobini C, Romeo G, Lenti L, Sale P, Gradini R, Liu FT, Di Mario U.

    Diabetes. 2000 Jul;49(7):1249-57.PMID: 10909985 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity